Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the relative bioavailability of intranasal fluticasone furoate and levocabastine has been completed. The trial involved allergic rhini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Furoate (fluticasone furoate)
  • Levocabastine (levocabastine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial and Seasonal | Phase 1 | Status: COMPLETED